An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
A metastatic prostate cancer diagnosis, which occurs when the cancer spreads beyond the prostate to other parts of the body, can feel scary and overwhelming. But new, targeted forms of treatment are ...
A head-to-head study of 108 prostate cancer patients shows gallium-68 PSMA PET/CT detects bone metastases far more accurately ...
A prospective study shows PSMA PET/CT-guided targeted biopsy detects clinically significant prostate cancer in 37 percent of men with negative or inconclusive MRI, nearly doubling detection when ...
Findings support the use of 18F-PSMA-1007 PET/CT in the preoperative workflow of intermediate- and high-risk prostate cancer. The use of 18 F-PSMA-1007 PET/CT showed improved results for the ...
Whole-pelvis RT linked to improved PFS for patients with prostate cancer staged TrN0M0, while ADT linked to improved PFS in patients staged N1/M1. (HealthDay News) — Prostate-specific membrane antigen ...
But new, targeted forms of treatment are available, and they are transforming the landscape of prostate cancer care. One of these newer treatments is called prostate-specific membrane antigen (PSMA) ...